Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
Assessment of long-term risks for VTE based on data from almost 30,000 childhood cancer survivors and siblings, with approximately 21 years of follow-up.
Assessment of long-term risks for VTE based on data from almost 30,000 childhood cancer survivors and siblings, with approximately 21 years of follow-up.
A comparison study of 2 approaches to radical hysterectomy found that disease-free and overall survival are worse with minimally invasive procedure than with abdominal open procedure, contradicting previous study findings.
Researchers analyzed data from more than 15,000 patients in Southern California with various cancers to identify clinical factors that contribute to the risk of developing chemotherapy-induced febrile neutropenia.
Results of an open-label phase 2 study demonstrated that a dose-escalation approach can prevent worsening anemia in patients with myelofibrosis undergoing treatment with ruxolitinib.
Survey also shows that Americans may be misinformed about alternative treatments for cancer.
A review of therapy options for relapsed/refractory DLBCL and FL compared SCT with chemotherapy/immunotherapy and experimental regimes. Patients fared better with SCT than other treatment modalities.
Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers.
In a review of data from the National Health Interview Survey, researchers identified the relationship between short and long sleep durations and diabetes in cancer survivors.
Researchers explored the feasibility of integrating pharmacists into the oncology care team for older patients with cancer to determine the impact this intervention would have on medication management and vaccination uptake.
A snapshot of an international Commission’s report on the issues inherent with adverse event reports of hematologic malingnancies in clinical trials.